|
Market Closed -
Nasdaq
23:00:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.540 USD | +4.02% |
|
+10.91% | +104.31% |
| 09-21 | Precigen Receives Fda Platform Technology Designation for Adenoverse Platform | CI |
| 09-21 | Precigen's AdenoVerse Receives FDA Platform Technology Designation | MT |
| Market Cap | 2.94B 2.61B 2.44B 2.22B 4.19B 283B 4.23B 29.5B 11.43B 144B 11.04B 10.8B 464B | P/E 2026 * |
38.3x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.94B 2.61B 2.44B 2.22B 4.19B 283B 4.23B 29.5B 11.43B 144B 11.04B 10.8B 464B | EV / Sales 2026 * |
12.3x | EV / Sales 2027 * | 6.63x |
| Free-Float |
87.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PGEN | Delayed | |
CBOE
| PGEN | Real-time | |
|
Tradegate
| I5X | Real-time | |
|
Boerse Muenchen
| I5X | Real-time | |
|
Deutsche Boerse AG
| I5X | Delayed | |
|
Börse Stuttgart
| I5X | Delayed |
Last Transcript: Precigen, Inc.
| 1 day | +4.02% | ||
| 1 week | +10.91% | ||
| Current month | -0.23% | ||
| 1 month | +24.49% | ||
| 3 months | +62.67% | ||
| 6 months | +117.30% | ||
| Current year | +104.31% |
| 1 week | 7.5 |  | 8.98 |
| 1 month | 6.54 | | 8.98 |
| Current year | 3.04 | | 8.98 |
| 1 year | 2.99 | | 8.98 |
| 3 years | 0.65 | | 8.98 |
| 5 years | 0.65 | | 8.98 |
| 10 years | 0.65 | | 32.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Harry Thomasian
DFI | Director of Finance/CFO | 64 | 01/10/2021 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Randal Kirk
CHM | Chairman | 72 | 01/02/2008 |
Cesar Alvarez
BRD | Director/Board Member | 78 | 01/02/2008 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 28/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/23/26 A | Exercice | Chief Financial Officer | 107,330 | 0.0360% | ||
| 8/26/26 A | Sell | Director | -185,000 | 0.0620% | ||
| 8/25/26 A | Exercice | Executive/Senior Manager | 237,498 | 0.0796% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.02% | +10.91% | +155.69% | +501.41% | 2.94B | |
| -0.61% | -3.30% | +38.46% | +112.77% | 1,025B | |
| -1.02% | -5.41% | +37.61% | +64.39% | 623B | |
| +1.11% | -0.87% | +7.55% | +76.32% | 459B | |
| +0.34% | -2.49% | +60.10% | +40.17% | 355B | |
| -0.95% | -4.87% | +22.46% | +38.03% | 336B | |
| -1.46% | -2.20% | +11.84% | +23.94% | 270B | |
| -1.35% | -4.27% | -4.55% | +6.92% | 247B | |
| -1.04% | -0.74% | +35.02% | +49.96% | 220B | |
| -1.87% | -3.31% | +30.22% | +93.14% | 183B | |
| Average | -0.27% | -1.04% | +39.44% | +100.70% | 372.12B | |
| Weighted average by Cap. | -0.58% | -2.10% | +29.82% | +68.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 239M 212M 198M 180M 340M 22.95B 344M 2.4B 929M 11.73B 896M 877M 37.66B | 444M 394M 368M 335M 632M 42.64B 638M 4.45B 1.72B 21.8B 1.67B 1.63B 69.96B |
| Net income | 86.06M 76.47M 71.37M 65.05M 123M 8.27B 124M 864M 335M 4.23B 323M 316M 13.57B | 246M 218M 204M 186M 350M 23.6B 353M 2.46B 955M 12.07B 922M 902M 38.72B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | $8.540 | +4.02% | 6,361,672 |
| 01/10/26 | $8.210 | -4.09% | 4,613,738 |
| 30/09/26 | $8.560 | +6.34% | 11,685,477 |
| 29/09/26 | $8.050 | +3.07% | 4,138,331 |
| 28/09/26 | $7.810 | +0.77% | 3,491,108 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PGEN Stock
Select your edition
All financial news and data tailored to specific country editions
